A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension.
Gudula J A M BoonWilbert B van den HoutAlexandru GrigoreanHarm Jan BogaardMarion DelcroixMenno V HuismanStavros V KonstantinidesLilian J MeijboomEsther J NossentPetr SymerskyAnton Vonk NoordegraafFrederikus Albertus KlokPublished in: ERJ open research (2021)
Our constructed model based on the Dutch healthcare setting demonstrates a substantial health gain when CTEPH is diagnosed earlier. According to Dutch health economic standards, additional costs remain below the deemed acceptable limit of EUR 50 000/QALY for the particular disease burden. This model can be used for evaluating cost-effectiveness of diagnostic strategies aimed at reducing the diagnostic delay.